You are here

Practice Management


Patients who quit smoking after an acute MI had improvements in their health-related quality of life and mental health, as well as reductions in angina, according to an analysis of two multicenter, prospective cohort studies.


Recent Headlines

PCSK9 inhibitor approvals provide LDL cholesterol-lowering options

As expected, the FDA approved evolocumab (Repatha) on Aug. 27, providing an option for patients who struggle to lower their low-density lipoprotein (LDL) cholesterol with statins. In July, the FDA had approved alirocumab (Praluent), which like evolocumab is a proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor.

Studies identify gene associated with sudden cardiac death

Two studies detected a gene that was associated with life-threatening heart rhythms that can lead to sudden cardiac death if not treated.

FDA approves second PCSK9 inhibitor

The FDA approved evolocumab (Repatha) on Aug. 27, the second in a new class of cholesterol-lowering medications called proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors.

Discontinuing antihypertensive treatment does not benefit older adults with mild cognitive impairment

Among older adults with mild cognitive deficits, discontinuing the use of antihypertensive medications did not improve their cognitive, psychological and general daily functioning.

Cardiorespiratory fitness improvements reduce risk of atrial fibrillation

Obese individuals with atrial fibrillation had a decreased risk of arrhythmia recurrence if they improved their cardiorespiratory fitness, according to an Australian observational study. The researchers found a gain in cardiorespiratory fitness provided a 12 percent incremental improvement over weight loss in long-term freedom from atrial fibrillation.

Heart disease mortality rates are declining, but vary by age and sex

Since 1979, coronary heart disease mortality rates have significantly decreased in the U.S., although they differ depending on age and sex. The rates for men and women under age 55 have remained relatively consistent and stagnated since 2000, according to a study published online in Circulation on Aug. 24. During that same time period, the rates for people 65 and older have rapidly declined.

More than one-third of older adults receive statins despite not having vascular disease

More than one-third of adults older than 79 years old used statins in 2011 to 2012 for primary prevention, a statistically significant increase from fewer than 10 percent in 1999 to 2000, according to a survey of community-dwelling U.S. adults.

Heart disease and stroke death rates increase in first quarter of 2015

For the first quarter of 2015, the death rates for heart disease and stroke increased slightly compared with the same time period last year, according to a Centers for Disease Control and Prevention (CDC) report.

CDC launches initiative to control hypertension

The Centers for Disease Control and Prevention (CDC) has launched the Million Hearts Hypertension Control Challenge, an initiative that recognizes physician practices that achieve hypertension control rates of 70 percent or higher.

Trans fats are associated with increased risk for heart disease and death

A systematic review and meta-analysis of observational studies found trans fats were associated with an increased risk for all cause mortality, total coronary heart disease and coronary heart disease mortality. However, the researchers from Canada also found that saturated fats were not associated with all cause mortality, cardiovascular disease, coronary hear disease, coronary heart disease mortality, ischemic stroke or type 2 diabetes.